Clene Inc. (CLNN)
NASDAQ·Healthcare·Biotechnology
$4.12
+4.30%
Mkt Cap $51.08M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$50.00
Range $50.00 – $50.00
Implied Upside
+1113.7%
Consensus $50.00 vs current $4.12
NASDAQ·Healthcare·Biotechnology
$4.12
+4.30%
Mkt Cap $51.08M
No recent rating data.
Price Target (1 analysts)
$50.00
Range $50.00 – $50.00
+1113.7%
Consensus $50.00 vs current $4.12